Inactive Instrument

Press Releases NovAccess Global Inc. Other OTC

Equities

XSNX

US67001N1072

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

NovAccess Global : Announces New License to Advance its Immunotherapy Platform	Apr. 30	PU
NovAccess Global Announces $10.7 Million Financing	Jan. 03	AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	Dec. 01	NE
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	23-07-28	AQ
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	23-07-13	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-06-23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-06-12	AQ
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	23-05-12	AQ
NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	23-05-11	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-05-02	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	23-03-16	AQ
NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award	23-03-15	PU
NovAccess Global to Present at World Orphan Drug Congress	23-02-17	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-02-14	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-02-13	AQ
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	23-02-06	AQ
NovAccess Global : Material Agreement - Form 8-K	23-01-23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-23	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-01-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NovAccess Global Inc. Other OTC

Equities

XSNX

US67001N1072

Press Releases

Filters